BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35713891)

  • 1. Evaluation of the Hybrid Tracer Indocyanine Green- 99m Tc-Nanocolloid for Sentinel Node Biopsy in Bladder Cancer-A Prospective Pilot Study.
    Rietbergen DDD; van Gennep EJ; KleinJan GH; Donswijk M; Valdés Olmos RA; van Rhijn BW; van der Poel HG; van Leeuwen FWB
    Clin Nucl Med; 2022 Sep; 47(9):774-780. PubMed ID: 35713891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A hybrid radioactive and fluorescence approach is more than the sum of its parts; outcome of a phase II randomized sentinel node trial in prostate cancer patients.
    Wit EMK; KleinJan GH; Berrens AC; van Vliet R; van Leeuwen PJ; Buckle T; Donswijk ML; Bekers EM; van Leeuwen FWB; van der Poel HG
    Eur J Nucl Med Mol Imaging; 2023 Jul; 50(9):2861-2871. PubMed ID: 37036490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multispectral Fluorescence Imaging During Robot-assisted Laparoscopic Sentinel Node Biopsy: A First Step Towards a Fluorescence-based Anatomic Roadmap.
    van den Berg NS; Buckle T; KleinJan GH; van der Poel HG; van Leeuwen FWB
    Eur Urol; 2017 Jul; 72(1):110-117. PubMed ID: 27345689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hybrid Indocyanine Green-
    Dell'Oglio P; de Vries HM; Mazzone E; KleinJan GH; Donswijk ML; van der Poel HG; Horenblas S; van Leeuwen FWB; Brouwer OR
    Eur Urol; 2020 Dec; 78(6):865-872. PubMed ID: 32950298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A hybrid radioactive and fluorescent tracer for sentinel node biopsy in penile carcinoma as a potential replacement for blue dye.
    Brouwer OR; van den Berg NS; Mathéron HM; van der Poel HG; van Rhijn BW; Bex A; van Tinteren H; Valdés Olmos RA; van Leeuwen FW; Horenblas S
    Eur Urol; 2014 Mar; 65(3):600-9. PubMed ID: 24355132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can Intraoperative Fluorescence Imaging Identify All Lesions While the Road Map Created by Preoperative Nuclear Imaging Is Masked?
    Meershoek P; Buckle T; van Oosterom MN; KleinJan GH; van der Poel HG; van Leeuwen FWB
    J Nucl Med; 2020 Jun; 61(6):834-841. PubMed ID: 31712325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing the hybrid fluorescent-radioactive tracer indocyanine green-99mTc-nanocolloid with 99mTc-nanocolloid for sentinel node identification: a validation study using lymphoscintigraphy and SPECT/CT.
    Brouwer OR; Buckle T; Vermeeren L; Klop WM; Balm AJ; van der Poel HG; van Rhijn BW; Horenblas S; Nieweg OE; van Leeuwen FW; Valdés Olmos RA
    J Nucl Med; 2012 Jul; 53(7):1034-40. PubMed ID: 22645297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Head-to-head comparison of the hybrid tracer indocyanine green-99mTc-nanocolloid with 99mTc-Senti-Scint using sentinel node lymphoscintigraphy and single-photon emission computed tomography combined with computer tomography in melanoma.
    Rietbergen DDD; Meershoek P; KleinJan GH; Donswijk M; Valdés Olmos RA; van Leeuwen FWB; Klop MWMC; van der Hage JA
    Nucl Med Commun; 2020 Oct; 41(10):1010-1017. PubMed ID: 32925825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of two hybrid sentinel node tracers: indocyanine green (ICG)-
    Vreeburg MTA; Azargoshasb S; van Willigen D; Molenaar T; van Oosterom MN; Buckle T; Slof LJ; Klop M; Karakullukcu B; Donswijk M; van der Poel HG; van Leeuwen FWB; Brouwer OR; Rietbergen DDD
    Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2282-2291. PubMed ID: 36929210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sentinel lymphadenectomy in cervical cancer using near infrared fluorescence from indocyanine green combined with technetium-99m-nanocolloid.
    Soergel P; Kirschke J; Klapdor R; Derlin T; Hillemanns P; Hertel H
    Lasers Surg Med; 2018 Dec; 50(10):994-1001. PubMed ID: 29968916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sentinel Node Identification with Hybrid Tracer-guided and Conventional Dynamic Sentinel Node Biopsy in Penile Cancer: A Prospective Study in 130 Patients from the Two National Referral Centres in Sweden.
    Torbrand C; Warnolf Å; Glombik D; Davidsson S; Carlsson J; Baseckas G; Håkansson U; Trägårdh E; Geijer H; Liedberg F; Kirrander P
    Eur Urol Oncol; 2022 Dec; 5(6):704-711. PubMed ID: 36272960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-Dimensional Tumor Margin Demarcation Using the Hybrid Tracer Indocyanine Green-
    Meershoek P; van den Berg NS; Brouwer OR; Teertstra HJ; Lange CAH; Valdés-Olmos RA; van der Hiel B; Balm AJM; Klop WMC; van Leeuwen FWB
    J Nucl Med; 2019 Jun; 60(6):764-769. PubMed ID: 30504140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between intraprostatic tracer deposits and sentinel lymph node mapping in prostate cancer patients.
    Buckle T; Brouwer OR; Valdés Olmos RA; van der Poel HG; van Leeuwen FW
    J Nucl Med; 2012 Jul; 53(7):1026-33. PubMed ID: 22645296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Added value of the hybrid tracer indocyanine green-99mTc-nanocolloid for sentinel node biopsy in a series of patients with different lymphatic drainage patterns.
    Frontado LM; Brouwer OR; van den Berg NS; Mathéron HM; Vidal-Sicart S; van Leeuwen FW; Valdés Olmos RA
    Rev Esp Med Nucl Imagen Mol; 2013; 32(4):227-33. PubMed ID: 23567320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multimodal surgical guidance towards the sentinel node in vulvar cancer.
    Mathéron HM; van den Berg NS; Brouwer OR; Kleinjan GH; van Driel WJ; Trum JW; Vegt E; Kenter G; van Leeuwen FW; Valdés Olmos RA
    Gynecol Oncol; 2013 Dec; 131(3):720-5. PubMed ID: 24051219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of ICG-
    Paredes P; Vidal-Sicart S; Campos F; Tapias A; Sánchez N; Martínez S; Carballo L; Pahisa J; Torné A; Ordi J; Carmona F; Lomeña F
    Eur J Nucl Med Mol Imaging; 2017 Oct; 44(11):1853-1861. PubMed ID: 28492965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a radioactive and fluorescent hybrid tracer for sentinel lymph node biopsy in head and neck malignancies: prospective randomized clinical trial to compare ICG-(99m)Tc-nanocolloid hybrid tracer versus (99m)Tc-nanocolloid.
    Stoffels I; Leyh J; Pöppel T; Schadendorf D; Klode J
    Eur J Nucl Med Mol Imaging; 2015 Oct; 42(11):1631-1638. PubMed ID: 26025245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimodal Surgical Guidance during Sentinel Node Biopsy for Melanoma: Combined Gamma Tracing and Fluorescence Imaging of the Sentinel Node through Use of the Hybrid Tracer Indocyanine Green-(99m)Tc-Nanocolloid.
    van den Berg NS; Brouwer OR; Schaafsma BE; Mathéron HM; Klop WM; Balm AJ; van Tinteren H; Nieweg OE; van Leeuwen FW; Valdés Olmos RA
    Radiology; 2015 May; 275(2):521-9. PubMed ID: 25521776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimodal hybrid imaging agents for sentinel node mapping as a means to (re)connect nuclear medicine to advances made in robot-assisted surgery.
    KleinJan GH; van den Berg NS; de Jong J; Wit EM; Thygessen H; Vegt E; van der Poel HG; van Leeuwen FW
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1278-87. PubMed ID: 26768422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concomitant radio- and fluorescence-guided sentinel lymph node biopsy in squamous cell carcinoma of the oral cavity using ICG-(99m)Tc-nanocolloid.
    van den Berg NS; Brouwer OR; Klop WM; Karakullukcu B; Zuur CL; Tan IB; Balm AJ; van den Brekel MW; Valdés Olmos RA; van Leeuwen FW
    Eur J Nucl Med Mol Imaging; 2012 Jul; 39(7):1128-36. PubMed ID: 22526966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.